Your browser doesn't support javascript.
loading
Combination of Niraparib, Cisplatin and Twist Knockdown in Cisplatin-Resistant Ovarian Cancer Cells Potentially Enhances Synthetic Lethality through ER-Stress Mediated Mitochondrial Apoptosis Pathway.
Bahar, Entaz; Kim, Ji-Ye; Kim, Dong-Chul; Kim, Hyun-Soo; Yoon, Hyonok.
Afiliação
  • Bahar E; College of Pharmacy, Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju 52828, Korea.
  • Kim JY; Department of Pathology, Ilsan Paik Hospital, Inje University, Goyang 10380, Korea.
  • Kim DC; Department of Pathology, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju 52828, Korea.
  • Kim HS; Samsung Medical Center, Department of Pathology and Translational Genomics, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
  • Yoon H; College of Pharmacy, Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju 52828, Korea.
Int J Mol Sci ; 22(8)2021 Apr 10.
Article em En | MEDLINE | ID: mdl-33920140

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteínas Nucleares / Resistencia a Medicamentos Antineoplásicos / Proteína 1 Relacionada a Twist / Mitocôndrias Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteínas Nucleares / Resistencia a Medicamentos Antineoplásicos / Proteína 1 Relacionada a Twist / Mitocôndrias Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2021 Tipo de documento: Article